BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1615333)

  • 1. Management of anemia in oncology. Introduction.
    Adamson JW
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):1-2. PubMed ID: 1615333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
    Fandrey JK; Jelkmann WE
    Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin--improving the quality of life of dialysis patients.
    Kionka C
    J Biotechnol; 1995 Nov; 43(1):73-4. PubMed ID: 8573324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effects of recombinant human erythropoietin therapy.
    Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN
    Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin].
    Uhl D
    Med Monatsschr Pharm; 1990 May; 13(5):130-1. PubMed ID: 2192242
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human erythropoietin. Experimental and clinical applications.
    Nielsen OJ
    Dan Med Bull; 1991 Oct; 38(5):355-70. PubMed ID: 1802621
    [No Abstract]   [Full Text] [Related]  

  • 10. Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin.
    Brown SM
    Prof Nurse; 1992 Feb; 7(5):282-3, 286-7. PubMed ID: 1738775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of renal anemia with recombinant erythropoietin. International workshop. Wolfenbüttle, November 22-24, 1987. Proceedings.
    Contrib Nephrol; 1988; 66():1-211. PubMed ID: 3391026
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of erythropoietin for nephrology].
    Watzinger U; Peer G; Barnas U; Mayer G; Luger A; Kovarik J; Graf H
    Wien Klin Wochenschr; 1990 Mar; 102(5):125-30. PubMed ID: 2181782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human recombinant erythropoietin to correct severe preoperative anemia.
    Fullerton DA; Campbell DN; Whitman GJ
    Ann Thorac Surg; 1991 May; 51(5):825-6. PubMed ID: 2025094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 15. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1990; 12(1):1-3. PubMed ID: 2178456
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin 1991--an overview.
    Eschbach JW
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):3-9. PubMed ID: 1928076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW; Eschbach JW
    Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.